AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
The launch comes against the backdrop of a significant public health burden
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
The graduating cohort comprised seven batches across five specialized programs
The program expected to commence in August 2026 will be offered across multiple specialised areas with an intake of 20-30 students per course
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
Rahul brings over 17 years of experience in human resources leadership across the healthcare, banking, information technology, and FMCG sectors
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Subscribe To Our Newsletter & Stay Updated